MedTrace Logo

Weight Loss and Prevention in Latina Immigrants: Advancing Methods of Community-Based Intervention Delivery

NCT02344212 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2015-01-22

No results posted yet for this study

Summary

The long-term objective of this study protocol is to develop and test a culturally sensitive, community-based intervention, ESENCIAL Para Vivir (Essential for Life) to promote weight loss and diabetes prevention among overweight or obese Latina immigrants. We chose to focus on Latinas because Latinas are at especially high risk for developing diabetes and currently there are not Spanish programs available in our area that provide education about weight management and diabetes prevention.

Conditions

Interventions

BEHAVIORAL

ESENCIAL Para Vivir: a weight loss program for Latinas

Overweight or obese Latina immigrant women were recruited to participate an 8-week weight loss program to reduce or delay their risk of developing diabetes. Data was collected at baseline, program completion, and six months.

Sponsors & Collaborators

  • UAB Diabetes Research Center

    collaborator UNKNOWN

  • UAB Nutrition Obesity Research Center

    collaborator UNKNOWN

  • UAB Minority Health & Research Center

    collaborator UNKNOWN

  • Robert Wood Johnson Foundation

    collaborator OTHER

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Andrea L Cherrington, MD MPH · University of Alabama at Birmingham

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2011-06-30
Completion
2011-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02344212 on ClinicalTrials.gov